Electrophysiologic and electrocardiographic effects, efficacy and safety of encainide in malignant ventricular arrhythmias associated with coronary artery disease
- 1 October 1990
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 66 (12) , 947-953
- https://doi.org/10.1016/0002-9149(90)90931-p
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial InfarctionNew England Journal of Medicine, 1989
- Treatment of life-threatening ventricular tachycardia with encainide hydrochloride in patients with left ventricular dysfunctionThe American Journal of Cardiology, 1988
- Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: The CAPSThe American Journal of Cardiology, 1988
- Encainide in lethal ventricular arrhythmias evaluated by electrophysiologic testing and decrease in symptomsThe American Journal of Cardiology, 1986
- Dose-response range of encainide for benign and potentially lethal ventricular arrhythmiasThe American Journal of Cardiology, 1986
- Comparative study of encainide and quinidine in the treatment of ventricular arrhythmiasJournal of the American College of Cardiology, 1986
- Encainide for refractory ventricular tachyarrhythmiaThe American Journal of Cardiology, 1983
- Possible contribution of encainide metabolites to the long-term antiarrhythmic efficacy of encainideThe American Journal of Cardiology, 1983
- Antiarrhythmic efficacy of encainide in patients with refractory recurrent ventricular tachycardia.Circulation, 1981
- Total Suppression of Ventricular Arrhythmias by EncainideNew England Journal of Medicine, 1980